Food and Drug Administration have reported increased numbers of Emergency Room Visits and hospitalizations related to complications caused by GLP-1 medications
the information below is extrapolated from authorised GLP-1 and GLP-1/GIP receptor agonists (such as semaglutide and tirzepatide) and should be interpreted accordingly
Eat less through GLP-1 suppression
Hypoglycaemia: When used alongside insulin or sulfonylureas, there is an increased risk of low blood sugar
Whats more, that ASCO study suggests that GLP-1 drugs have a notable impact on cancer risk, even when patients dont lose a lot of weight as a result of taking them
Not intended for human consumption, medical use, veterinary use, diagnostic procedures, therapeutic applications, or household use.